Stock Information
Quest Diagnostics Inc (DGX)
Ticker Symbol: DGX
Exchange: NYSE
Sector: Health Care
Market Cap: $23,285.25 mil
Piotroski score: 8
PE Ratio: 23.7489
EPS (TTM): 8.5244
Revenue (TTM): $96.02 M
Dividend Yield: 1.6629604%
ROE: 13.75%
Latest News
-
Dividend Champion, Contender, And Challenger Highlights: Week Of February 15
Fri, Feb 13, 2026 6:33 PM
-
A Look At Quest Diagnostics (DGX) Valuation After Strong Results, 2026 Outlook, Buybacks And New Myeloma Test
Fri, Feb 13, 2026 12:12 PM
-
Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.86
Fri, Feb 13, 2026 11:18 AM
-
Mizuho Maintains Outperform on Quest Diagnostics, Raises Price Target to $235
Thu, Feb 12, 2026 9:23 AM
-
Forecasting The Future: 6 Analyst Projections For Quest Diagnostics
Wed, Feb 11, 2026 6:00 PM
-
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?
Wed, Feb 11, 2026 2:15 PM
-
Truist Securities Maintains Hold on Quest Diagnostics, Raises Price Target to $220
Wed, Feb 11, 2026 12:38 PM
-
UBS Maintains Neutral on Quest Diagnostics, Raises Price Target to $210
Wed, Feb 11, 2026 12:20 PM
-
Evercore ISI Group Maintains In-Line on Quest Diagnostics, Raises Price Target to $220
Wed, Feb 11, 2026 10:24 AM
-
Barclays Maintains Overweight on Quest Diagnostics, Raises Price Target to $225
Wed, Feb 11, 2026 10:19 AM
Key Financials
Financial data not available
